You just read:

Intraoperative Molecular Imaging of Non-Small Cell Lung Cancer Improves Outcomes for 26 Percent of Patients in Multi-Institutional Phase 2 Clinical Trial

News provided by

On Target Laboratories, Inc.

Jan 27, 2020, 15:00 ET